Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kataoka K et al. – The strategy of a DNA–based mucosal adjuvant facilitates the targeting of mucosal dendritic cells, and thus is an effective and safe approach. It would also provide great flexibility for the development of effective vaccines for various mucosal pathogens.


Today in Vaccine/Immunotherapy...keeping you current

Overview of hypersensitivity to cancer therapies
Community Oncology , 03/19/10

Radioimmunotherapy: a promising treatment strategy for follicular lymphoma
Community Oncology , 03/19/10

Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid-encoded cytokines against Mycobacterium bovis
Immunology & Cell Biology, 03/19/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address